BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11776796)

  • 21. Biliary carcinoembryonic antigen levels in diagnosis of occult hepatic metastases from colorectal carcinoma.
    Waisberg J; Palma RT; Neto LC; Martins LC; Oliveira MS; Nagashima CA; Godoy AC; Goffi FS
    World J Gastroenterol; 2003 Jul; 9(7):1589-93. PubMed ID: 12854170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.
    Kim Y; Lee S; Park S; Jeon H; Lee W; Kim JK; Cho M; Kim M; Lim J; Kang CS; Han K
    Ann Clin Lab Sci; 2003; 33(1):32-8. PubMed ID: 12661896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer.
    Iwanicki-Caron I; Di Fiore F; Roque I; Astruc E; Stetiu M; Duclos A; Tougeron D; Saillard S; Thureau S; Benichou J; Paillot B; Basuyau JP; Michel P
    J Clin Oncol; 2008 Aug; 26(22):3681-6. PubMed ID: 18669452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical significance of serum CEA determination in the diagnosis of colo-rectal cancer].
    Jiang R
    Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):348-51. PubMed ID: 2620629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of carcinoembryonic antigen in colorectal malignancy.
    Mazumdar A; Verma GR; Bose SM; Ganguly NK
    Trop Gastroenterol; 1999; 20(3):107-10. PubMed ID: 10695415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of liver metastasis of colorectal cancer following hepatic arterial infusion with degradable starch microspheres and adriamycin, mitomycin C as seen in changes in CEA at early stage of therapy].
    Takeuchi I; Ishida H; Hashimoto D; Mastumoto Y; Miura T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1686-8. PubMed ID: 14619494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatic lymph node involvement in patients with synchronous multiple liver metastases of colorectal cancer].
    Ishibashi K; Ohsawa T; Yokoyama M; Ishizuka N; Miyazaki T; Nakada H; Gonda T; Ishida H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1834-7. PubMed ID: 17212121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of CEA level determination in gallbladder bile in the diagnosis of liver metastases secondary to colorectal adenocarcinoma.
    Moura RM; Matos D; Galvão Filho MM; D'Ippólito G; Sjzenfeld J; Giuliano LM
    Sao Paulo Med J; 2001 May; 119(3):110-3. PubMed ID: 11391453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of serum CEA protein and CEA mRNA after resection of colorectal liver metastases.
    Kijima M; Togo S; Ichikawa Y; Miura M; Yamagishi S; Matsuo K; Tanaka K; Masui H; Ishikawa T; Ike H; Shimada H
    Anticancer Res; 2005; 25(2B):1327-32. PubMed ID: 15865086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer].
    Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in liver metastases of colorectal cancer].
    Porembska Z; Skwarek A; Chrzanowska A; Mielczarek M; Nyckowski P; Barańczyk-Kuźma A
    Pol Merkur Lekarski; 2004 Jan; 16(91):31-3. PubMed ID: 15074017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study.
    Oussoultzoglou E; Rosso E; Fuchshuber P; Stefanescu V; Diop B; Giraudo G; Pessaux P; Bachellier P; Jaeck D
    Arch Surg; 2008 Dec; 143(12):1150-8; discussion 1158-9. PubMed ID: 19075165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
    Zhao XW; Jiang B; Han CZ; Jing JX
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
    Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
    Park JY; Lee KH
    Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.
    Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M
    Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis.
    Chen CY; Shiesh SC; Tsao HC; Lin XZ
    Hepatogastroenterology; 2002; 49(45):616-20. PubMed ID: 12063953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sensitivity, specificity and prognostic value of CEA in colorectal cancer: results of a Tunisian series and literature review].
    Bel Hadj Hmida Y; Tahri N; Sellami A; Yangui N; Jlidi R; Beyrouti MI; Krichen MS; Masmoudi H
    Tunis Med; 2001; 79(8-9):434-40. PubMed ID: 11774785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].
    Grotowski M; Maruszyński M; Piechota W
    Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.
    El-Awady S; Lithy R; Morshed M; Khafagy W; Abd Monem H; Waleed O; Badr S; Fekry A; El Nakeeb A; Ghazy H; El Yamany M; Metwally T; El-Arman M; Farid M
    Hepatogastroenterology; 2009; 56(90):361-6. PubMed ID: 19579599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.